2430-01-5

Basic information

• Product Name: 2-bromo-N,N-diethyl-acetamide
• Synonyms: 2-bromo-N,N-diethyl-ethanamide;2-bromo-N,N-diethylacetamide(SALTDATA: FREE)
• CAS NO: 2430-01-5
• Molecular Formula: C₆H₁₂BrNO
• Molecular Weight: 194.08
• Mol File: 2430-01-5.mol
• Article Data: 35

Chemical Properties

• Boiling Point: 219°Cat760mmHg
• Flash Point: 86.2°C
• Appearance: /
• Density: 1.337g/cm³
• Vapor Pressure: 0.122mmHg at 25°C
• Refractive Index: 1.481
• CAS DataBase Reference: 2-bromo-N,N-diethyl-acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-N,N-diethyl-acetamide(2430-01-5)
• EPA Substance Registry System: 2-bromo-N,N-diethyl-acetamide(2430-01-5)

Safety Data

• Hazardous Substances Data: 2430-01-5(Hazardous Substances Data)

Usage

General Description

2-bromo-N,N-diethyl-acetamide is a chemical compound with the molecular formula C6H12BrNO and a molar mass of 202.07 g/mol. It is a colorless to pale yellow liquid with a pungent odor, and it is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2-bromo-N,N-diethyl-acetamide is a brominated derivative of N,N-diethylacetamide, and it is commonly used as a reagent in organic synthesis and as a building block for the preparation of various functionalized compounds. It is important to handle this chemical with caution as it is a corrosive and irritant to the eyes, skin, and respiratory system. Proper safety precautions should be taken when working with 2-bromo-N,N-diethyl-acetamide, including the use of gloves, goggles, and a fume hood.

InChI:InChI=1/C6H12BrNO/c1-3-8(4-2)6(9)5-7/h3-5H2,1-2H3

Upstream product

• 109-89-7 diethylamine 
• 598-21-0 2-Bromoacetyl bromide 
• 79-08-3 bromoacetic acid 
• 22118-09-8 2-bromoacetyl chloride 
• 39096-01-0 N,N-diethyl-2-hydroxyacetamide 
• 7087-68-5 N-ethyl-N,N-diisopropylamine 
• 2315-36-8 2-Chloro-N,N-diethylacetamide 

Downstream Products

• 23784-83-0 4-methoxy-cinnamic acid diethylamide 
• 30487-30-0 furan-2-carboxylic acid 3-(diethylcarbamoyl-methyl)-5-nitro-3H-thiazol-2-ylideneamide 
• 71037-00-8 (N,N-dicarbamoylmethyl) diphenyldithiophosphinate 
• 5408-58-2 β-hydroxy-isovaleric acid diethylamide 
• 137653-90-8 (E)-N,N-Diethyl-3-pentafluorophenyl-acrylamide 
• 2602-61-1 N,N-diethyldecanamide 
• 124397-92-8 N,N-diethyl-3,3,3-trifluoropropionamide 
• 996-97-4 N,N-diethyloctanamide 
• 143035-31-8 2-[4-(3,6-Dimethyl-4-oxo-4,5-dihydro-pyrazolo[4,3-c]pyridin-1-yl)-phenoxy]-N,N-diethyl-acetamide 
• 118494-98-7 2-(7,7'-Bis-benzyloxy-2'-diethylcarbamoylmethoxy-[1,1']binaphthalenyl-2-yloxy)-N,N-diethyl-acetamide 
• 118282-59-0 2-(4-tert-Butyl-1-hydroxy-cyclohexyl)-N,N-diethyl-acetamide 
• 289687-05-4 tert-butyl 4-[N-[7-chloro-3-diethylcarbamoylmethyl-4-oxo-2-piperidin-1-ylmethyl-3,4-dihydroquinazolin-6-ylmethyl]-N-(prop-2-ynyl)amino]benzoate 
• 96650-00-9 cis-N,N-Diaethyl-3-phenyl-glycidamid 
• 96650-00-9 trans-N,N-diethyl-3-phenyl-2,3-epoxypropionamide 

Relevant articles and documents

A new facile synthesis of a thromboxane B2 precursor

A short, stereocontrolled synthesis of a key intermediate in the synthesis of thromboxane B2 is described. The approach is based on the use of N,N-diethyl(phenylsulfonyl)acetamide as nucleophile in a palladium-catalysed nucleophilic substitutio

Facile peripheral modification of N-confused porphyrin

An improved methodology for the N-alkylation of the porphyrin isomer N-confused porphyrin is presented. The combination of polar solvent conditions and the use of the base Cs2CO3 affords externally modified products in high yield wit

Quaternary ammonium salt type honokiol/magnolol derivative as well as preparation method and application thereof

The invention discloses a series of novel quaternary ammonium salt honokiol/magnolol derivatives as well as a preparation method and application thereof. According to the series of compounds, honokiol/magnolol is taken as a raw material, a series of novel quaternary ammonium salt honokiol/magnolol derivatives are prepared on phenolic hydroxyl groups of honokiol/magnolol through a coupling reaction, and the structural general formula is shown in the specification. The compound disclosed by the invention has very strong antibacterial activity on staphylococcus aureus ATCC 29213 and clinically separated methicillin-resistant staphylococcus aureus (MRSA), most of the derivatives are higher than parent honokiol/magnolol, and the activity of part of the target derivatives is higher than that of a contrast drug levofloxacin. The compound is expected to be used for preparing drugs for resisting staphylococcus aureus and methicillin-resistant staphylococcus aureus.

Design, Synthesis, Antimicrobial Evaluation, and Laccase Catalysis Effect of Novel Benzofuran–Oxadiazole and Benzofuran–Triazole Hybrids

Novel structural hybrids of benzofuran–oxadiazole and benzofuran–triazole have been synthesized and evaluated for their potential against Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. The excellent antibiotic activity was shown by compou